Investigator Grant Management at Scale: How Large Sponsors are Taking Control

‍

‍Investigator grants are one of the largest and least visible line items in a clinical trial budget, and managing them at scale is one of the hardest problems in R&D finance. In this session, Auxilius COO and Co-Founder Erin Warner Guill breaks down how enterprise biopharma sponsors are bringing transparency to investigator grant spend across large portfolios, using data they already have.

Link to on-demand recording.‍
Link to presentation materials.

This session covers:

• 0:00 The core challenges of managing investigator grants at scale
• 15:00 Bridging site CTAs, the EDC, and payments reporting
• 27:42 Building a data backbone, and where AI fits
• 38:16 Investigator payments reconciliation in action
• 51:48 Real-time forecasting for investigator spend